Frank Hsu

Director/Miembro de la Junta en Karin Grunebaum Cancer Research Foundation .

63 años

Health Technology

Consumer Services

Retail Trade

Perfil

Frank J.
Hsu is a trustee at Karin Grunebaum Cancer Research Foundation.
He was a Senior Director-Medical at Genzyme Corp.
from 2002 to 2012, and Director-Immunology Research Programs at Yale Cancer Center from 1996 to 2002.
He was also a Researcher at Stanford University from 1990 to 1996.
From 2012 to 2013, he served as the Chief Medical Officer at Zyngenia, Inc. He was the Vice President & Head-Oncology at Immune Design Corp.
from 2014 to 2018.
Currently, he is the Chief Medical Officer at Oncternal Therapeutics, Inc. and the Chief Marketing Officer at Apexigen, Inc. Hsu received his undergraduate degree from Stanford University and his doctorate from Harvard Medical School.

Cargos activos de Frank Hsu

Empresas	Cargo	Inicio
Karin Grunebaum Cancer Research Foundation	Director/Miembro de la Junta	-

Todos los cargos activos de Frank Hsu

Antiguos cargos conocidos de Frank Hsu.

Empresas	Cargo	Fin
APEXIGEN, INC.	Director Técnico/Científico/I+D	23/08/2023
IMMUNE DESIGN CORP	Corporate Officer/Principal	01/01/2018
Zyngenia, Inc. Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD.	Director Técnico/Científico/I+D	01/06/2013
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Director Técnico/Científico/I+D	01/01/2012
Yale Cancer Center Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT.	Corporate Officer/Principal	01/01/2002

Ver el detalle de la experiencia de Frank Hsu.

Formación de Frank Hsu.

Stanford University	Undergraduate Degree
Harvard Medical School	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Frank Hsu.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
ONCTERNAL THERAPEUTICS, INC.	Health Technology
APEXIGEN, INC.	Health Technology

Empresas privadas	5
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Zyngenia, Inc. Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD.	Retail Trade
Yale Cancer Center Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT.	Health Services
Immune Design Corp. Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ.	Health Technology
Karin Grunebaum Cancer Research Foundation

Ver las conexiones de la empresa